A series of novel 1-(N-indolyl)-1,3-butadienes, as (1 : 1) mixtures of the (E) and (Z) dienes, was prepared in one step by base-catalysed isomerization of N-alkylindoles with a terminal butyne chain. The reaction conditions are mild, and in all cases the yields were very high (>90%). The (E) and (Z) dienes were separable by preparative TLC and could be fully characterized. This isomerization proceeded readily in the case of a butynyl chain, but didn't take place with a pentynyl chain. A mechanism was proposed for this reaction, based on previous studies on the isomerization of alkynes in basic media, and a key intermediate that supports the proposed mechanism could be isolated and fully characterized. A theoretical study of the proposed mechanism was performed by computational methods and the results validated the proposal. The reactivity of the synthesized dienes was studied in Diels–Alder reactions with p-benzoquinone, to obtain a small library of new 5-(N-indolyl)-1,4-naphthoquinones.The lack of reactivity in the case of the (Z) isomers was explained by calculation of the rotational curves of the central bond of the (Z) and (E) dienes. Finally, the cytotoxicity of the new 5-(N-indolyl)-1,4-naphthoquinones was tested against a panel of three cell lines.
Since the early stages of modern medicine, natural products have been a source of inspiration for the development of bioactive compounds. Around half of approved small molecule drugs trace their origins to natural products or their derivatives, highlighting the importance of their correct classification and identification. The information generated by the experimental groups is not usually unified, and is available only in publications or general databases, where the compounds are not linked to their natural sources. To address this need, numerous natural product databases specific to distinct geographic regions have emerged. In this work, we introduce NaturAr, a natural products database dedicated to the cataloging of the rich biodiversity of Argentina. At the time of submission, 228 papers were reviewed, leading to a database of more than 1200 compounds from all across the country. A distinctive quality of this database is its collaborative and open-source framework, which promotes contributions from the research community. NaturAr is freely available online at https://naturar.quimica.unlp.edu.ar.
The outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19, has caused a global health crisis. Unfortunately, only a few treatments have proved to be effective, and their worldwide distribution remains as a challenge. Due to the urgency of the situation, drug repurposing remains as the fastest way to identify possible therapeutic options. Recent studies have shown that the stabilization of non-native Protein-Protein Interactions (PPIs) of the nucleocapsid protein of MERS coronavirus is a valid strategy to inhibit viral replication, but no study up to date has been done in SARS-CoV-2. In this work, a novel protocol for the discovery of PPIs stabilizers is presented and applied to SARS-CoV-2 N protein with a drug repurposing approach. This enabled us to identify that catechin, a structural motif present in widely distributed natural products, might be a privileged scaffold for this type of stabilization. Since many of the compounds presented in this work are generally considered nutraceuticals and have also been exhaustively studied, even though some of them contain PAINS substructures, could be good candidates for the SARS-CoV-2 nucleocapsid inhibition and be considered for further in vitro testing against COVID-19.
The outbreak of COVID-19, the disease caused by SARS-CoV-2, continues to affect millions of people around the world. The absence of a globally distributed effective treatment makes the exploration of new mechanisms of action a key step to address this situation. Stabilization of non-native Protein-Protein Interactions (PPIs) of the nucleocapsid protein of MERS-CoV has been reported as a valid strategy to inhibit viral replication. In this study, the applicability of this unexplored mechanism of action against SARS-CoV-2 is analyzed. During our research, we were able to find three inducible interfaces of SARS-CoV-2 N protein NTD, compare them to the previously reported MERS-CoV stabilized dimers, and identify those residues that are responsible for their formation. A drug discovery protocol implemented consisting of docking, molecular dynamics and MM-GBSA enabled us to find several compounds that might be able to exploit this mechanism of action. In addition, a common catechin skeleton was found among many of these molecules, which might be useful for further drug design. We consider that our findings could motivate future research in the fields of drug discovery and design towards the exploitation of this previously unexplored mechanism of action against COVID-19.